162 related articles for article (PubMed ID: 37499740)
1. CD105 in the progression and therapy of renal cell carcinoma.
Oladejo M; Nguyen HM; Wood L
Cancer Lett; 2023 Aug; 570():216327. PubMed ID: 37499740
[TBL] [Abstract][Full Text] [Related]
2. Tumoral CD105 promotes immunosuppression, metastasis, and angiogenesis in renal cell carcinoma.
Oladejo M; Nguyen HM; Seah H; Datta A; Wood LM
Cancer Immunol Immunother; 2023 Jun; 72(6):1633-1646. PubMed ID: 36586013
[TBL] [Abstract][Full Text] [Related]
3. Neovascularity as a prognostic marker in renal cell carcinoma.
Bauman TM; Huang W; Lee MH; Abel EJ
Hum Pathol; 2016 Nov; 57():98-105. PubMed ID: 27436827
[TBL] [Abstract][Full Text] [Related]
4. Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells.
Khan MI; Czarnecka AM; Lewicki S; Helbrecht I; Brodaczewska K; Koch I; Zdanowski R; Król M; Szczylik C
PLoS One; 2016; 11(11):e0165718. PubMed ID: 27812180
[TBL] [Abstract][Full Text] [Related]
5. Expression of CEACAM1 and CD105 in Renal Cell Carcinoma and Its Correlation with Microvessel Density.
Kang ZP; Wang LX; Liu J; Ouyang H; Xie S; Tan Y
Crit Rev Eukaryot Gene Expr; 2021; 31(1):1-9. PubMed ID: 33639050
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma.
Raica M; Cimpean AM; Anghel A
Neoplasma; 2007; 54(4):278-84. PubMed ID: 17822316
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD105 cancer stem cell marker in three subtypes of renal cell carcinoma.
Saeednejad Zanjani L; Madjd Z; Abolhasani M; Shariftabrizi A; Rasti A; Asgari M
Cancer Biomark; 2018; 21(4):821-837. PubMed ID: 29286924
[TBL] [Abstract][Full Text] [Related]
8. Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy.
Kasprzak A; Adamek A
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563158
[TBL] [Abstract][Full Text] [Related]
9. Dendritic-cell-based immunotherapy evokes potent anti-tumor immune responses in CD105+ human renal cancer stem cells.
Zhang XF; Weng DS; Pan K; Zhou ZQ; Pan QZ; Zhao JJ; Tang Y; Jiang SS; Chen CL; Li YQ; Zhang HX; Chang AE; Wicha MS; Zeng YX; Li Q; Xia JC
Mol Carcinog; 2017 Nov; 56(11):2499-2511. PubMed ID: 28621442
[TBL] [Abstract][Full Text] [Related]
10. Histopathological analysis of angiogenic factors in renal cell carcinoma.
Yagasaki H; Kawata N; Takimoto Y; Nemoto N
Int J Urol; 2003 Apr; 10(4):220-7. PubMed ID: 12657102
[TBL] [Abstract][Full Text] [Related]
11. Functional significance of CD105-positive cells in papillary renal cell carcinoma.
Matak D; Brodaczewska KK; Szczylik C; Koch I; Myszczyszyn A; Lipiec M; Lewicki S; Szymanski L; Zdanowski R; Czarnecka AM
BMC Cancer; 2017 Jan; 17(1):21. PubMed ID: 28056882
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑218 inhibits tumor angiogenesis of human renal cell carcinoma by targeting GAB2.
Mu L; Guan B; Tian J; Li X; Long Q; Wang M; Wang W; She J; Li X; Wu D; Du Y
Oncol Rep; 2020 Nov; 44(5):1961-1970. PubMed ID: 32901879
[TBL] [Abstract][Full Text] [Related]
13. Heterogenous expression of endoglin marks advanced renal cancer with distinct tumor microenvironment fitness.
Momoi Y; Nishida J; Miyakuni K; Kuroda M; Kubota SI; Miyazono K; Ehata S
Cancer Sci; 2021 Aug; 112(8):3136-3149. PubMed ID: 34091990
[TBL] [Abstract][Full Text] [Related]
14. Emerging role of endoglin (CD105) as a marker of angiogenesis with clinical potential in human malignancies.
Fonsatti E; Sigalotti L; Arslan P; Altomonte M; Maio M
Curr Cancer Drug Targets; 2003 Dec; 3(6):427-32. PubMed ID: 14683500
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the prognostic significance of endoglin (CD105) in clear cell renal cell carcinoma using automated image analysis.
Dubinski W; Gabril M; Iakovlev VV; Scorilas A; Youssef YM; Faragalla H; Kovacs K; Rotondo F; Metias S; Arsanious A; Plotkin A; Girgis AH; Streutker CJ; Yousef GM
Hum Pathol; 2012 Jul; 43(7):1037-43. PubMed ID: 22204709
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs Associated with Von Hippel-Lindau Pathway in Renal Cell Carcinoma: A Comprehensive Review.
Schanza LM; Seles M; Stotz M; Fosselteder J; Hutterer GC; Pichler M; Stiegelbauer V
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165391
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis in breast cancer: the role of transforming growth factor beta and CD105.
Li C; Guo B; Bernabeu C; Kumar S
Microsc Res Tech; 2001 Feb; 52(4):437-49. PubMed ID: 11170303
[TBL] [Abstract][Full Text] [Related]
18. CD105 is important for angiogenesis: evidence and potential applications.
Duff SE; Li C; Garland JM; Kumar S
FASEB J; 2003 Jun; 17(9):984-92. PubMed ID: 12773481
[TBL] [Abstract][Full Text] [Related]
19. CD105 as a tool for assessing microvessel density in renal cell carcinoma.
Cioca A; Muntean D; Bungardean C
Indian J Pathol Microbiol; 2019; 62(2):239-243. PubMed ID: 30971547
[TBL] [Abstract][Full Text] [Related]
20. Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche.
Grange C; Tapparo M; Collino F; Vitillo L; Damasco C; Deregibus MC; Tetta C; Bussolati B; Camussi G
Cancer Res; 2011 Aug; 71(15):5346-56. PubMed ID: 21670082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
